JPH07227294A - Production of pseurotin a - Google Patents

Production of pseurotin a

Info

Publication number
JPH07227294A
JPH07227294A JP6039143A JP3914394A JPH07227294A JP H07227294 A JPH07227294 A JP H07227294A JP 6039143 A JP6039143 A JP 6039143A JP 3914394 A JP3914394 A JP 3914394A JP H07227294 A JPH07227294 A JP H07227294A
Authority
JP
Japan
Prior art keywords
medium
culture
pseurotin
shurotin
ifo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6039143A
Other languages
Japanese (ja)
Inventor
Tokiyuki Hiramitsu
時幸 平光
Chiaki Yasuhara
千晶 安原
Katsunori Suzuki
功徳 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Mektron KK
Original Assignee
Nippon Mektron KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Mektron KK filed Critical Nippon Mektron KK
Priority to JP6039143A priority Critical patent/JPH07227294A/en
Publication of JPH07227294A publication Critical patent/JPH07227294A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PURPOSE:To produce pseurotin A having antagonism on apomorphine, etc., by culturing Cordyceps ophioglossoides (IFO-8992) of a fungus, forming and accumulating pseurotin A and collecting the product. CONSTITUTION:One platinum loop of Cordyceps ophioglossoides (IFO-8992) of a fungus is inoculated into a medium and subjected to static culture at 25 deg.C for 20 days. The culture solution is uniformly inoculated into the surface of a potato dextrose agar medium and subjected to static culture at 25 deg.C for 20 days at a dark place. The cultured medium is heated, melted, mixed with n- butanol, stirred at 100 deg.C for 3 hours and cooled to room temperature. An n- butanol layer separated from the solidified agar medium is concentrated and the prepared residue is purified by silica gel chromatography to give the objective pseurotin A of the formula, having antagonism on apomorphine and incitory action on monoamine oxidase.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、シュウロチンAの製造
方法に関する。更に詳しくは、微生物を培養してシュウ
ロチンAを製造する方法に関する。
TECHNICAL FIELD The present invention relates to a method for producing shurotin A. More specifically, it relates to a method for culturing microorganisms to produce shurotin A.

【0002】[0002]

【従来の技術】シュウロチンA(Pseurotin A)は、ヘテ
ロスピロ環を含むユニークな構造を有する化合物、即ち
2-[1´(S),2´(S)-ジヒドロキシヘキシ-3´-ン-イル]-
3-メチル-8(S)-メトキシ-8-ベンゾイル-9(R)-ヒドロキ
シ-(5S)-1-オキサ-7-アザスピロ[4,4]ノン-2-エン-4,6-
ジオン
2. Description of the Related Art Pseurotin A is a compound having a unique structure containing a heterospiro ring,
2- [1 '(S), 2' (S) -dihydroxyhex-3'-n-yl]-
3-Methyl-8 (S) -methoxy-8-benzoyl-9 (R) -hydroxy- (5S) -1-oxa-7-azaspiro [4,4] non-2-ene-4,6-
Zeon

【化1】 である。この化合物は、シューデューロチウム オバリ
ス ストークの培養液から初めて単離され(Helv.Chim.
Acta 第59巻第1号第133頁、1976年,同誌第64巻第1号第
304頁、1981年)、その後シューダレス チェリア ボイジ
やアスペルギルスフミガタスの培養代謝産物としても単
離が報告されている(Proc.Japan Assoc.Mycotoxyco
l.第22巻第33頁、1985年,EP 546 475)。
[Chemical 1] Is. This compound was isolated for the first time from the culture fluid of Pseudorotium ovalisstork (Helv. Chim.
Acta Vol. 59, No. 1, page 133, 1976, Vol. 64, No. 1, No.
(P. 304, 1981), and then isolated as a cultured metabolite of Pseudoles celia vage and Aspergillus fumigatus (Proc. Japan Assoc. Mycotoxyco.
l. Volume 22, p. 33, 1985, EP 546 475).

【0003】生物活性についても種々研究され、アポモ
ルフィン拮抗作用やモノアミン酸化酵素に対する阻害作
用が知られており(上記 Proc.Japan Assoc.Mycotoxyc
ol.および EP)、それの有効利用が期待されている。し
かしながら、それの製造方法には満足すべきものがな
く、例えばシューデューロチウム オバリス ストークの
培養培地からは、培地1L当り30〜35mgの収量でシュウ
ロチンAが、またアスペルギルス フミガタスの培養培
地からは、培地1L当り10mgの収量でシュウロチンAと
シュウロチンDとの混合物が得られているにすぎない。
Various studies have been conducted on biological activity, and apomorphine antagonism and inhibition of monoamine oxidase are known (see Proc. Japan Assoc. Mycotoxyc above).
ol. And EP), and effective use of it is expected. However, its production method is unsatisfactory, and for example, from the culture medium of Pseudorotium ovalisstork, shurotin A was obtained in a yield of 30 to 35 mg per liter of the medium, and from the culture medium of Aspergillus fumigatus, the medium of 1 L was used. Only a mixture of Schurotin A and Schurotin D is obtained with a yield of 10 mg per.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、微生
物を培養してシュウロチンAを製造するに際し、高産生
能力を有する方法を提供することにある。
SUMMARY OF THE INVENTION An object of the present invention is to provide a method having a high production capacity when culturing a microorganism to produce shurotin A.

【0005】[0005]

【課題を解決するための手段】かかる本発明の目的は、
微生物コージセプス オフィオグロソィデス(IFO 8992)
を培養し、シュウロチンAを生成、蓄積せしめて、これ
を採取してシュウロチンAを製造する方法によって達成
される。
The object of the present invention is as follows.
Microbial Koji Seps Ophioglossoides (IFO 8992)
It is achieved by a method of culturing cultivated sucrose, producing and accumulating shurotin A, and collecting it to produce shurotin A.

【0006】微生物コージセプス オフィオグロソィデ
ス(Cordyceps ophioglossoides)は、古来より重要な漢
方薬として用いられている冬虫夏草(コージセプス シネ
ンシス)と同属に属し、日本ではハナヤスリタケと呼ば
れ、ツチダンゴ類に寄生するキノコの一種である。しか
しながら、その生物活性代謝産物に関する研究は少な
く、培養代謝産物とし、抗カビ作用のあるオフィオコル
ジンや抗腫瘍活性のあるガラクトサミノグリカンなどが
知られているにすぎない(Arch.Microbiol.第113巻第1
21頁、1977年,Agric.Biol.Chem.第51巻第10号第280
5頁、1987年)。
[0006] The microorganism Koji Ceps ophioglossoides belongs to the same genus as Cordyceps sinensis, which has been used as an herbal medicine that has been important since ancient times. It is a kind. However, there are few studies on its biologically active metabolites, and as culture metabolites, ophiocordine having antifungal activity and galactosaminoglycan having antitumor activity are known (Arch. Microbiol. 113). First
21, p. 1977, Agric. Biol. Chem. Vol. 51, No. 10, 280
5 pages, 1987).

【0007】本発明方法においては、かかる微生物コー
ジセプス オフィオグロソィデスが培養に用いられる。
それの培養は、通常の真菌培養法によって行われる。即
ち、静置培養法または振とう培養法が用いられ、培地と
しては、この菌株が利用し得る栄養源を含有するもので
あれば、合成培地、半合成培地、天然培地のいずれをも
用いることができる。
[0007] In the method of the present invention, the microorganism Koji Ceps ophiogrosides is used for culturing.
The culture thereof is carried out by a usual fungal culture method. That is, a stationary culture method or a shaking culture method is used, and as the medium, any of synthetic medium, semi-synthetic medium and natural medium may be used as long as it contains a nutrient source that can be utilized by this strain. You can

【0008】培地中には、例えば炭素源としてぶとう
糖、麦芽糖、しょ糖、デキストリン、グリセリン、でん
粉、じゃがいも煎汁、おがくず、コーンミル等が、窒素
源として麦芽エキス、大豆粉、コーン・スチーブ・リカ
ー、綿実粉、肉エキス、酵母エキス、ペプトン、じゃが
いも煎汁、カゼイン加水分解物、乾燥酵母、米ぬか、ア
ミノ酸類、アンモニウム塩、硝酸塩等が、また必要に応
じて無機塩としてナトリウム、カリウム、マグネシウ
ム、カルシウム、亜鉛、鉄等の硫酸塩、硝酸塩、炭酸
塩、リン酸塩、塩化物等がそれぞれ含有され、培地が固
体培地として用いられる場合には、更にゲル化剤として
寒天、ゼラチン、シリカゲル、ゲランガム等が含有され
る。
In the medium, for example, dextrose, maltose, sucrose, dextrin, glycerin, starch, potato decoction, sawdust, corn mill, etc. as carbon sources, malt extract, soybean powder, corn steve liquor as nitrogen sources. , Cottonseed flour, meat extract, yeast extract, peptone, potato decoction, casein hydrolyzate, dry yeast, rice bran, amino acids, ammonium salts, nitrates, etc., and if necessary, inorganic salts such as sodium, potassium and magnesium. , Calcium, zinc, iron and other sulfates, nitrates, carbonates, phosphates, chlorides and the like, respectively, when the medium is used as a solid medium, further agar, gelatin, silica gel, as a gelling agent, Gellan gum and the like are contained.

【0009】培養は、好気的条件下で行うのが一般的に
有利であり、培養温度としては約20〜30℃、pHは約5〜8
の範囲がそれぞれ好ましく、また培養時間は培地の組
成、培養温度などにより変動するが、一般には1週間か
ら1ヶ月程度であり、この間にシュウロチンAが培地中
に生成蓄積される。
It is generally advantageous to carry out the culture under aerobic conditions. The culture temperature is about 20 to 30 ° C. and the pH is about 5 to 8.
The respective ranges are preferable, and the culturing time varies depending on the composition of the medium, the culturing temperature, etc., but is generally about 1 week to 1 month, during which shurotin A is produced and accumulated in the medium.

【0010】培地中に生成蓄積されたシュウロチンAの
培地からの採取は、微生物の培養培地より代謝産物を分
離精製する通常の手段を、適宜選択し組み合わせること
によって行われ、その概略を示すと次の如くである。
Collection of shurotin A produced and accumulated in the medium from the medium is carried out by appropriately selecting and combining ordinary means for separating and purifying metabolites from the culture medium of the microorganism, and the outline thereof is as follows. Is like.

【0011】即ち、液体培地からシュウロチンAを分離
する場合には、培養後の培地から菌糸体を除去後、酢酸
エチルで抽出する。抽出液を濃縮乾固した後、得られた
残渣をカラムクロマトグラフィーで精製し、更にHPLCで
精製する。固体培地からシュウロチンAを分離する場合
には、固体培地を粉砕した後、シュウロチンAを溶解せ
しめる有機溶媒、例えばメタノール、n-ブタノール等の
アルコール中にけん濁し、室温条件下または加熱条件下
で抽出し、抽出液から固形物を除去した後、60℃以下の
温度で減圧濃縮乾固し、残渣をカラムクロマトグラフィ
ーおよびHPLCで精製する。
That is, in the case of separating shurotin A from the liquid medium, the mycelium is removed from the medium after culturing and then extracted with ethyl acetate. After the extract is concentrated to dryness, the obtained residue is purified by column chromatography and further by HPLC. In the case of separating shurotin A from the solid medium, after crushing the solid medium, the solid medium is suspended in an organic solvent capable of dissolving shurotin A, for example, alcohol such as methanol or n-butanol, and extracted under room temperature or heating conditions. After removing solids from the extract, the mixture is concentrated to dryness under reduced pressure at a temperature of 60 ° C or lower, and the residue is purified by column chromatography and HPLC.

【0012】[0012]

【発明の効果】微生物コージセプス オフィオグロソィ
デス(IFO 8992)を培養することにより、シュウロチンA
を高産生能力で製造することができる。
EFFECT OF THE INVENTION By culturing the microorganism Koji Cepth Ophioglossoides (IFO 8992), shurotin A
Can be produced with high production capacity.

【0013】[0013]

【実施例】次に、実施例について本発明を説明する。EXAMPLES The present invention will now be described with reference to examples.

【0014】実施例1 コージセプス オフィオグロソィデス(IFO 8992)の傾斜
培養物の一白金耳を、容量200mlのエルレンマイヤーフ
ラスコ内の種培養用培地(栄研化学製品ポテトデキスト
ロース寒天培地39gを蒸留水1Lにけん濁し、不溶寒天部
分をロ別後、オートクレーブ中で120℃、15分間の滅菌
処理をしたもの)20mlに接種し、25℃で20日間静置培養
した。この培養液20mlを、本培養用培地(栄研化学製品
ポテトデキストロース寒天培地39gを蒸留水1Lにけん濁
し、オートクレーブ中で120℃、15分間の滅菌処理をし
た後、長さ30cm、幅22cm、深さ6cmのステンレス鋼製ふ
た付きバットに注入して調製したもの)の表面に均一に
接種した後、滅菌したナイフで約2cm角のサイコロ状に
切断した。それぞれのサイコロ状培地と空気との接触を
よくするため、相互に密着しないように、バット内に不
規則に配置され、25℃で21日間暗所で静置培養した。
Example 1 One platinum loop of a tilted culture of Koji Ceps ophiogrosides (IFO 8992) was placed in a medium for seed culture in an Erlenmeyer flask with a capacity of 200 ml (39 g of Eiken Chemical's potato dextrose agar medium was distilled). After suspending in 1 L of water and separating the insoluble agar portion by filtration, 20 ml of it was sterilized in an autoclave at 120 ° C. for 15 minutes) and inoculated to 20 ml, followed by stationary culture at 25 ° C. for 20 days. 20 ml of this culture broth was suspended in 1 L of distilled water (39 g of Eiken Chemicals potato dextrose agar medium) for main culture, and sterilized in an autoclave at 120 ° C for 15 minutes, and then 30 cm in length, 22 cm in width, (Prepared by pouring into a 6 cm-deep stainless steel lid vat) was uniformly inoculated on the surface, and then cut into about 2 cm square dice with a sterilized knife. In order to improve the contact between each dice-shaped medium and air, they were randomly placed in a vat so as not to adhere to each other, and statically cultured at 25 ° C. for 21 days in the dark.

【0015】培養後の培地は、加熱して溶融させた後、
500mlのn-ブタノールを加え、100℃で3時間撹拌した。
室温に冷却した後、固化した寒天培地から分離したn-ブ
タノール層を濃縮乾固した。得られた残渣を、シリカゲ
ルカラムクロマトグラフィー(ワコーゲル C-300 30g、
溶離液:ベンゼン/酢酸エチル=1/1)で精製し、シュウ
ロチンA 60mgを淡黄色の粗粉末として得た。これを更
にHPLC(カラム イナートシルプレップODS、溶離液:メ
タノール/水=55/45)で精製し、シュウロチンA 45mgを
無色の結晶として得た。この結晶の融点、1H NMRスペク
トル、13C NMRスペクトル、IRスペクトルは、前記文献
記載のデータと良く一致し、シュウロチンAと同定され
た。
The medium after culturing is heated and melted,
500 ml of n-butanol was added, and the mixture was stirred at 100 ° C for 3 hours.
After cooling to room temperature, the n-butanol layer separated from the solidified agar medium was concentrated to dryness. The obtained residue was subjected to silica gel column chromatography (Wako Gel C-300 30 g,
The eluent: benzene / ethyl acetate = 1/1) was used for purification to obtain 60 mg of shurotin A as a pale yellow crude powder. This was further purified by HPLC (column inert sylprep ODS, eluent: methanol / water = 55/45) to obtain 45 mg of shurotin A as colorless crystals. The melting point, 1 H NMR spectrum, 13 C NMR spectrum, and IR spectrum of this crystal were in good agreement with the data described in the above literature, and were identified as shurotin A.

【0016】実施例2 実施例1において、本培養用培地として麦芽エキス含有
寒天培地(DIFCO製品麦芽エキス10g、DIFCO製品 BACTO-
ペプトン1g、ブドウ糖40g、寒天20g)を用い、シュウロ
チンAを37mg得た。
Example 2 In Example 1, malt extract-containing agar medium was used as the main culture medium (malt extract 10 g of DIFCO product, BACTO-product of DIFCO product).
Using 1 g of peptone, 40 g of glucose and 20 g of agar), 37 mg of shurotin A was obtained.

【0017】実施例3 コージセプス オフィオグロソィデス(IFO 8992)の傾斜
培養物の一白金耳を、種培養用培地(栄研化学製品ポテ
トデキストロース寒天培地39gを蒸留水1Lにけん濁し、
オートクレーブ中で120℃、15分間の滅菌処理後、熱時
に10mlずつ、径9cm、深さ20mmのシャーレに分注したも
の)の1枚の中心に接種し、25℃で7日間静置培養した。
このようにして得られた円形のコロニーを、滅菌したメ
スで20等分し、その全部を本培養用培地(実施例1での
種培養用培地と同じ組成の培地)1Lを含む容量5Lのエ
ルレンマイヤーフラスコ中に接種し、25℃で2週間、暗
所で静置培養した。
EXAMPLE 3 One platinum loop of a tilted culture of Koji Ceps ophiogrosides (IFO 8992) was suspended in a seed culture medium (Eiken Chemicals potato dextrose agar 39 g in distilled water 1 L).
After sterilization at 120 ° C for 15 minutes in an autoclave, 10 ml of each was inoculated into the center of a petri dish having a diameter of 9 cm and a depth of 20 mm when heated, and inoculated into a center of one plate, and statically cultured at 25 ° C for 7 days .
The circular colonies thus obtained were divided into 20 equal parts with a sterilized scalpel, and all of them were contained in a volume of 5 L containing 1 L of a main culture medium (medium having the same composition as the seed culture medium of Example 1). The cells were inoculated into an Erlenmeyer flask and cultivated in the dark at 25 ° C for 2 weeks.

【0018】培養終了後、菌糸体をロ過して除き、ロ液
を水で2倍に希釈した後、酢酸エチル1Lで2度抽出す
る。酢酸エチル層を水洗した後、50℃以下の温度で濃縮
乾固した。残渣を、シリカゲルカラムクロマトグラフィ
ー(ワコーゲル C-300 30g、溶離液:ベンゼン/酢酸エチ
ル=1/1)で精製し、更にHPLC(カラム イナートシルプレ
ップODS、溶離液:メタノール/水=55/45)で精製して、
シュウロチンA 52mgを無色の結晶として得た。
After completion of the culture, the mycelium was removed by filtration, the filtrate was diluted with water twice, and then extracted twice with 1 L of ethyl acetate. The ethyl acetate layer was washed with water and then concentrated to dryness at a temperature of 50 ° C or lower. The residue was purified by silica gel column chromatography (Wakogel C-300 30g, eluent: benzene / ethyl acetate = 1/1) and further HPLC (column inert silt prep ODS, eluent: methanol / water = 55/45). Purified with
52 mg of Schurotin A was obtained as colorless crystals.

【0019】実施例4 実施例3において、本培養用培地として麦芽エキス含有
培養培地(DIFCO製品麦芽エキス10g、DIFCO製品 BACTO-
ペプトン1g、ブドウ糖40gを蒸留水1Lに溶解した後、1
20℃、15分間の滅菌処理をしたもの)を使用し、シュウ
ロチンAを31mg得た。
Example 4 In Example 3, a malt extract-containing culture medium (DIFCO product malt extract 10 g, DIFCO product BACTO- was used as a main culture medium.
Dissolve 1 g of peptone and 40 g of glucose in 1 L of distilled water, then
Sterilized at 20 ° C. for 15 minutes) was used to obtain 31 mg of shurotin A.

【0020】実施例5 実施例4の本培養用培地1Lを含む5Lのエルレンマイ
ヤーフラスコ中に、実施例3の円形コロニーを20等分し
たものを種菌として接種し、25℃で21日間振とう培養し
た。培養終了後、培地にエタノール1Lを加えて不溶物
をロ別し、ロ液を60℃以下の温度で濃縮乾固した。残渣
に、水200mlを加えた後、酢酸エチル200mlで抽出した。
酢酸エチル層を水洗、濃縮乾固した。得られた残渣を、
シリカゲルカラムクロマトグラフィー(ワコーゲル C-30
0 35g、溶離液:酢酸エチル/ベンゼン=1/1)で精製し、
更に分取用薄層クロマトグラフィー(メルク社製品 Art.
13895、展開溶媒:酢酸エチル/ベンゼン=3/2)で精製
して、シュウロチンA 57mgを無色の粉末として得た。
Example 5 A 5 L Erlenmeyer flask containing 1 L of the main culture medium of Example 4 was inoculated with 20 equally divided circular colonies of Example 3 as an inoculum and shaken at 25 ° C. for 21 days. Cultured. After completion of the culture, 1 L of ethanol was added to the medium to separate insoluble matter by filtration, and the filtrate was concentrated to dryness at a temperature of 60 ° C or lower. After adding 200 ml of water to the residue, the mixture was extracted with 200 ml of ethyl acetate.
The ethyl acetate layer was washed with water and concentrated to dryness. The resulting residue is
Silica gel column chromatography (Wako gel C-30
0 35 g, eluent: ethyl acetate / benzene = 1/1),
Furthermore, preparative thin-layer chromatography (Merck Company Art.
13895, developing solvent: ethyl acetate / benzene = 3/2) to obtain 57 mg of shurotin A as colorless powder.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 17/18 C12R 1:645) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location (C12P 17/18 C12R 1: 645)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 微生物コージセプス オフィオグロソィ
デス(IFO 8992)を培養し、シュウロチンAを生成、蓄積
せしめて、これを採取することを特徴とするシュウロチ
ンAの製造方法。
1. A method for producing shurotin A, which comprises culturing a microorganism Koji sepus Ophioglossoides (IFO 8992), producing and accumulating shurotin A, and collecting the shurotin A.
JP6039143A 1994-02-14 1994-02-14 Production of pseurotin a Pending JPH07227294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6039143A JPH07227294A (en) 1994-02-14 1994-02-14 Production of pseurotin a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6039143A JPH07227294A (en) 1994-02-14 1994-02-14 Production of pseurotin a

Publications (1)

Publication Number Publication Date
JPH07227294A true JPH07227294A (en) 1995-08-29

Family

ID=12544891

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6039143A Pending JPH07227294A (en) 1994-02-14 1994-02-14 Production of pseurotin a

Country Status (1)

Country Link
JP (1) JPH07227294A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020727A3 (en) * 2000-09-05 2003-01-16 Globoasia Llc Method for propagating fungi using solid state fermentation
CN102311442A (en) * 2010-06-29 2012-01-11 中国科学院微生物研究所 Spirolactam alkaloid compound with anti-tumor activity and preparation method as well as application thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020727A3 (en) * 2000-09-05 2003-01-16 Globoasia Llc Method for propagating fungi using solid state fermentation
US6558943B1 (en) 2000-09-05 2003-05-06 Sun Ten Pharmaceutical Co., Ltd. Method for propagating fungi using solid state fermentation
CN102311442A (en) * 2010-06-29 2012-01-11 中国科学院微生物研究所 Spirolactam alkaloid compound with anti-tumor activity and preparation method as well as application thereof

Similar Documents

Publication Publication Date Title
CA1046439A (en) Physiologically active substances from penicillium citrinum
JPH0764872B2 (en) FR901228 substance and its manufacturing method
JPH07227294A (en) Production of pseurotin a
US5202244A (en) Process for producing aphidicolin using the microrganism verticillium sp
US3975235A (en) Process for the production of cephamycin type antibiotic substances
JP4105805B2 (en) Novel antifungal active substances PF1163A and PF1163B substances, processes for producing them, and antifungal agents containing them as active ingredients
JPH07227289A (en) Microorganism metabolite and antitumor agent comprising the same as active ingredient
US3564019A (en) Tetracyclic lactone antifungal agents
JPH0246294A (en) Production of angnocyclinone from streptomyces microorganism and production thereof
JP3858061B2 (en) Novel chitinase inhibitor and process for producing the same
JP2872311B2 (en) FO-608B, C substance and method for producing the same
JP3030896B2 (en) WB968 substance group and production method thereof
JP2578486B2 (en) New substance KS-502
JP2004099456A (en) New physiologically active substance
JP4629442B2 (en) Process for producing β-L-homofuconojirimycin by microorganism
US3775433A (en) Antimicrobial metabolite s491beta and s491ypsilon and chemical derivatives
JPS61289898A (en) Production of factor for suppressing sporulation of phytopathogenic fungus
WO2004003214A1 (en) Solid state fermentation and fed batch for the production of an immunosuppressant
JPS59166094A (en) Preparation of physiologically active substance ml-236b
JPH05255184A (en) New compound ilicicolinic acid a or b
JP2002510335A (en) New compound WF00144
JPH01296992A (en) Substance fr-900493, production thereof and drug composition containing the same substance
JPH03219888A (en) Production of streptovaricin
JPS6212792B2 (en)
JP2001149088A (en) Production of optically active 1-substituted-3-amino-4- phenyl-2-butanol derivative